Overview
Neil Majithia is a Hematologist Oncology specialist and a Hematologist in Augusta, Maine. Dr. Majithia is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Lung Adenocarcinoma, and Small Lymphocytic Lymphoma (SLL).
His clinical research consists of co-authoring 15 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- OTHER MEDICAID
- STATE MEDICAID
- PPO
- HMO
- POS
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
361 Old Belgrade Rd, Augusta, ME 04330
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Mainegeneral Medical Center
George Polkinghorn is a Hematologist and an Oncologist in Augusta, Maine. Dr. Polkinghorn is rated as a Distinguished provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Paget Disease of the Breast.
Mainehealth
Youval Katz is a Hematologist Oncology specialist and a Hematologist in Brunswick, Maine. Dr. Katz is rated as a Distinguished provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Chronic Lymphocytic Leukemia (CLL), and Monoclonal Gammopathy of Undetermined Significance (MGUS).
Mainehealth
Sarah Ketchum is a Hematologist Oncology specialist and a Hematologist in Scarborough, Maine. Dr. Ketchum is rated as an Advanced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Multiple Myeloma, Familial Colorectal Cancer, Neuroendocrine Tumor, Breast Cancer, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerDr. Majithia isAdvanced. Learn about Breast Cancer.
- Paget Disease of the BreastDr. Majithia isAdvanced. Learn about Paget Disease of the Breast.
- Experienced
- Acute Mountain SicknessDr. Majithia isExperienced. Learn about Acute Mountain Sickness.
- Acute Promyelocytic LeukemiaDr. Majithia isExperienced. Learn about Acute Promyelocytic Leukemia.
- Adult Immune ThrombocytopeniaDr. Majithia isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Majithia isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Majithia isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Majithia isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.